<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">168</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> http://dx.doi.org/10.31782/IJMPS.2021.111101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Ufasomes: Rising Technology For Delivery of Drugs&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Luke</surname><given-names>P. Mereena</given-names></name></contrib><contrib contrib-type="author"><name><surname>Joseph</surname><given-names>Tomy Muringayil</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>10</day><month>11</month><year>2021</year></pub-date><volume>1)</volume><issue/><fpage>1</fpage><lpage>7</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>In a vesicular drug delivery system, one or more concentric bilayers of amphiphilic molecules cover an aqueous compartment. They are an excellent distribution method for targeted medication administration because of their ability to localise drug activity to the area or organ of function. The vesicular drug delivery system maintains the drug activity at a constant rate. As a consequence, the body__ampersandsignrsquo;s opioid frequency is maintained while unfavourable side effects are reduced. Unsaturated fatty acid vesicles are known as ufasomes. With a pH range of 7 to 9, they__ampersandsignrsquo;re pH-controlled suspensions of closed lipid bilayers made up of fatty acids and their ionised species (soap). Fatty acid vesicles are often made using the lipid film hydration technique. Oleic acid is the most significant fatty acid utilised as a primary component in the production of ufasomes. This study discusses the advantages, disadvantages, possible development, and categorization of ufasomes.&#13;
</p></abstract><kwd-group><kwd> Ufasome</kwd><kwd> Vesicular Drug Delivery System</kwd><kwd> Fatty Acid Vesicles</kwd><kwd> Development</kwd><kwd> Characterization</kwd><kwd> Applications</kwd></kwd-group></article-meta></front></article>
